$DOC

DOC Maintained by Wells Fargo -- Price Target Lowered to $19.00

Wells Fargo maintained an Equal-Weight rating on Healthpeak Properties (DOC) but lowered its price target to $19.00 from $22.00, citing a cautious market outlook. The stock is currently trading at $18.53, with a GF Value™ of $20.35, suggesting it is 8.9% undervalued. Healthpeak has a GF Score™ of 82/100, indicating strong overall performance but with concerns about financial strength.

Original reporting
Published Oct 19, 2026, 5:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 5:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DOC
Bearish
medium confidence
Mentioned
$DOC
Relevance
5/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$DOCBearishLow
01

Why it matters

Analyst downgrade may trigger short‑term price weakness, but the underlying business fundamentals remain solid.

02

Market read

The price‑target cut is a modest catalyst for DOC, with limited broader market impact.

03

What to watch

Recent merger with Physicians Realty Trust may provide long‑term growth not fully reflected in the new target.

Relevance 5/10Novelty 5/10Timing: post-market today

Background

Healthpeak Properties is a U.S. healthcare REIT with a market cap of ~$12.8 B. The firm completed a 2024 merger with Physicians Realty Trust.

Company-level read

Ticker impact

$DOCBearishMedium confidence
Context

Wells Fargo lowered its price target for Healthpeak Properties (DOC) to $19.00, indicating a bearish outlook.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

The target reduction of 13.6% signals reduced growth expectations, which may prompt short-term selling.

Market effects

May weigh on other healthcare REITs as analysts reassess sector valuation.

Limited to U.S. REIT market.

Low

Counterpoint

The stock could be undervalued given its strong cash flow and dividend yield despite the target cut.

Key entities

  • Wells Fargo

    Maintained Equal‑Weight rating while lowering price target.

  • Healthpeak Properties

    Healthcare REIT subject of the rating update.

Related articles

$CCIMed

Better High-Yield Dividend Stock: Crown Castle vs. Healthpeak

Crown Castle (CCI) and Healthpeak Properties (PEAK) both raised 2026 outlooks in Q2. CCI yields 5.4% with a 93% AFFO payout ratio for 2026, while PEAK yields 6.7% with a 78% ratio. CCI trades at 16x forward AFFO, PEAK at 12x. Both have cut dividends previously. CCI's Q2 AFFO rose to $1.13/share, with full-year outlook at $4.53-$4.65.

$DOCMedAI 8/10

Healthpeak (DOC) Turns Portfolio Sales Into Fatter 2026 Guidance

Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.

$DOCMed

Healthpeak Properties Q2 Earnings Call Highlights

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.

$DOCMed

Is Wall Street Bullish or Bearish on Healthpeak Properties Stock?

Healthpeak Properties (DOC) is a U.S. healthcare REIT with a $14.9B market cap. The stock rose 31.8% over the past year and nearly 41% in 2026. After Q2 2026 results on Aug. 4, revenue was $771.6M and adjusted FFO was $0.46, both above estimates. Full-year FFO guidance is $1.73 to $1.77. Analysts rate DOC a “Moderate Buy,” with Barclays holding a $23 target.

$DOCLow

Healthpeak Properties Reports Second Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance

HEALTHPEAK PROPERTIES, INC. (DOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Healthpeak Properties Reports Second Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance DENVER, August 4, 2026 - Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery